Literature DB >> 6267919

Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs.

R A Walsh, F R Badke, R A O'Rourke.   

Abstract

We examined the differential effects of intravenous (IV) equimolar doses of diltiazem (D), verapamil (V), and nifedipine (N) upon left ventricular (LV) function in 12 healthy unsedated dogs. We also attempted to isolate direct myocardial effects of these agents from reflex and peripheral effects by using intracoronary (IC) equimolar drug administration in an additional six animals. Despite equivalent dose-related increases in heart rate and declines in arterial pressure intravenous V (0.04, 0.1, 0.17 mg/kg) and N (0.3 mg/kg) but not D (0.04, 0.1, 0.17 mg/kg) depressed LV function. Peak effects after high dose V included increased heart rate (HR) (68%) and reduced mean aortic pressure (MAP) (17%), dP/dt max (22%), and percent shortening of the LV minor diameter (% delta D) (33%) (all p less than or equal to 0.001). By contrast, equimolar D increased HR (68%) and decreased MAP (20%) but produced no change in dP/dt or % delta D while low dose N (0.03 mg/kg) depressed dP/dt and % delta D by 37% and 45%, respectively (both p less than or equal to 0.001) despite similar changes in HR and MAP. Pretreatment with propranolol (2 mg/kg) and matching HR and loading conditions to control failed to uncover myocardial depression after D. Equimolar IC D, V (4, 8, 16 micrograms/kg), or N (3 micrograms/kg) each produced dose-related reductions in percent regional shortening which were greatest with N (58% at 3 micrograms/kg) and least with D (9% at 16 micrograms/kg). These data suggest that calcium channel blockers vary in their propensity to reduce LV function and that the myocardial depressant effects of these agents are partially offset by reflex and peripheral vascular actions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267919     DOI: 10.1016/0002-8703(81)90307-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

1.  Intracellular calcium increasing at the beginning of reperfusion assists the early recovery of myocardial contractility after diltiazem cardioplegia.

Authors:  Koichi Inoue; Susumu Ando; Taro Itagaki; Yasuhiro Shiojiri; Toshitaka Kashima; Toshihiro Takaba
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-03

Review 2.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  The hemodynamic properties of amlodipine in anesthetised and conscious dogs: comparison with nitrendipine and influence of beta-adrenergic blockade.

Authors:  M G Dodd; D G Gardiner; A J Carter; M R Sutton; R A Burges
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 4.  Calcium channel blocking agents and the heart.

Authors:  J Kenny
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

5.  Direct and indirect effects of calcium entry blocking agents on isovolumic left ventricular relaxation in conscious dogs.

Authors:  R A Walsh; R A O'Rourke
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

Review 6.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 7.  The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Authors:  C J Bulpitt; A E Fletcher; A Amery; J Coope; J G Evans; S Lightowlers; K O'Malley; A Palmer; J Potter; P Sever
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

8.  Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.

Authors:  M R Bristow; R Ginsburg; J A Laser; B J McAuley; W Minobe
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

9.  [Calcium antagonists in heart failure?].

Authors:  H Drexler; H Just
Journal:  Klin Wochenschr       Date:  1986-10-15

10.  Diltiazem treatment for the management of ischaemia in patients with poor left ventricular function: safety of long term administration.

Authors:  M J Zema; S Perlmutter; S Mankes; C Nikitopoulos
Journal:  Br Heart J       Date:  1987-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.